A prospective, randomized study of coadministration of ketoconazole and cyclosporine a in kidney transplant recipients: Ten-year follow-up

Transplantation

Volumn 77, Issue 9 SUPPL., 2004, Pages 1371-1376

  El Agroudy, Amgad E ^a   Sobh, Mohamed A ^a   Hamdy, Ahmed F ^a   Ghoneim, Mohamed A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYCLOSPORIN A; KETOCONAZOLE; PHOSPHORUS;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CALCIUM BLOOD LEVEL; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST CONTROL; DERMATOMYCOSIS; DRUG COST; DRUG DOSE REDUCTION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FINANCIAL MANAGEMENT; FOLLOW UP; GRAFT FUNCTION; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH CARE COST; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVER FUNCTION TEST; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTIFUNGAL AGENTS; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KETOCONAZOLE; KIDNEY TRANSPLANTATION; MALE; MYCOSES; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 2442666481     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000121133.84763.26     Document Type: Article

References (25)

1. Kramer NC, Peters TG, Rohr MS. Beneficial effect of cyclosporine on renal transplantation. Transplantation 1990; 49: 343-346.
2. Kai-Chung T, Tak-Mao C. Nephrotoxicity of immunosuppressive agents in renal transplantation. Hong Kong J Nephrol 2002; 4(2): 65-72.
3. Barclay PG, Allen RDM, Stewart JH, et al. Costs of immunosuppressive therapies used in renal transplantation. Transplant Proc 1992; 24: 165-166.
4. Evans RW, Manninen DL. Economic impact of cyclosporine in transplantation. Transplant Proc 1988; 20: 49-52.
5. Ferguson RM, Sutherland DER, Simmons RL, et al. Ketoconazole, cyclosporine metabolism and renal transplantation. Lancet 1982; 2: 882-883.
6. Schroeder TJ, Melvin DB, Clardy CW, et al. The use of cyclosporine and ketoconazole without nephrotoxicity in 2 heart transplant recipients. J Heart Transplant 1987; 6: 84-89.
7. Giradet RE, Melo JC, Fox MS, et al. Concomitant administration of cyclosporine and ketoconazole for three and half years in one heart transplant recipient. Transplantation 1989; 48(5): 887-890.
8. Butman SM, Wild JC, Nolan PE, et al. Prospective study of the safety and financial benefit of ketoconazole as adjunctive therapy to cyclosporine after heart transplantation. J Heart Lung Transplant 1991; 10: 351-358.
9. First MR, Schroeder TJ, Alexander JW, et al. Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients. Transplantation 1991; 51(2): 365-370.
10. First MR, Schroeder TJ, Michael A, et al. Cyclosporine-ketoconazole interaction. Long-term follow-up and preliminary results of a randomized trial. Transplantation 1993; 55(5): 1000-1004.
11. Abraham MA, Thomas PP, John GT, et al. Efficacy and safety of low-dose ketoconazole (50 mg) to reduce the cost of cyclosporine in renal allograft recipients Transplant Proc 2003; 35: 215-216.
12. Sobh M, El-Agroudy A, Mostafa F, et al. Co-administration of ketoconazole to cyclosporine treated kidney transplant recipients: A prospective randomized study. Am J Nephrol 1995; 15: 493-499.
13. Sobh MA, Hamdy AF, El-Agroudy AE, et al. Coadministration of ketoconazole and cyclosporine for kidney transplant recipients: long-term evaluation and study of metabolic consequences. Am J Kidney Dis 2001; 37(3): 510-517.
14. Thamer M, Chan JK, Ray NF, et al. Drug use concomitant with cyclosporine immunosuppressive therapy for 3 years after renal transplantation. Am J Kidney Dis 1998; 31(2): 283-292.
15. Odocha O, Kelly B, Trimble S, et al. Cost-containment strategies in transplantation: the utility of cyclosporine-ketoconazole combination therapy. Transplant Proc 1996; 28(2): 907-909.
16. Patton PR, Brunson MA, Pfaff WW, et al. A preliminary report of diltiazem and ketoconazole. Their cyclosporine-sparing effect and impact on transplant outcome. Transplantation 1994; 27; 57(6): 889-892.
17. Gueco IP, Tan-Torres T, Baniga U, et al. Ketoconazole in posttransplant triple therapy: comparison of costs and outcomes. Transplant Proc 1992; 24(5): 1709-1714.
18. Randall T. Cyclosporine-ketoconazole combination offers promise in reducing antirejection therapy costs. JAMA 1990; 264(4): 430-431.
19. Sobh MA, El-Agroudy AE, Moustafa FE, et al. Impact of schistosomiasis on patient and graft outcome after kidney transplantation. Nephrol Dial Transplant 1992; 7: 858-864.
20. Jeng S, Chanchairujira T, Jusko W, et al. Prednisolone metabolism in kidney or liver transplants and in lung recipients receiving ketoconazole. Transplantation 2003; 75(6): 792-795.
21. Watanabe T, Gao ZH, Shinozuka N, et al. Unexpectedly low immunocompetence in transplant patients on ketoconazole. Clin Transplant 1997; 11(6): 599-603.
22. Senior DS, Show JT. In vivo effects of fluconazole and ketoconazole on mouse lymphocyte proliferation and on candida blastospore destruction by human polymorphonuclear leucocytes. Int J Immunopharmacol 1988; 10: 169-176.
23. Zucher M, Frey BM, Frey FJ. Impact of ketoconazole on the metabolism of prednisolone. Clin Pharmacol Ther 1989; 45: 366-372.
24. Treivish VS, Shoikhet IN, Ankova EV. Combination of cyclosporine and ketoconazole in immunosuppression schemes in patients with transplanted kidney. Klin Med 1998; 76(1): 40-42.
25. Moore LW, Alloway RR, Achiardo SR, et al. Clinical observations of metabolic changes occurring in renal transplant recipients receiving ketoconazole. Transplantation 1996; 61(4): 537-541.